InvestorsHub Logo

rayovacAAA

10/29/20 3:53 PM

#279320 RE: nidan7500 #279315

AVXL IS GOING TO ANNOUNCE WORLD WIDE APPROVAL FOR THEIR ENTIRE PIPELINE PRIME TIME AT 11:00 A.M. EST ON 6 NOVEMBER 2020!!!!!!!!!!!!!!!!!!!


An observation on the message from FDA executive officer. He says treatment will change the progression, not just the symptoms. That's a different line and is more consistent with what AVXL has claimed.Cannot locate anywhere BIIB has made this claim.



Whatever the final decision by the FDA, this is an important moment. We have never before been this close to approval of a drug for Alzheimer’s that could change the progression of the disease, not just the symptoms.




6 NOVEMBER 2020 WILL BE A DAY WHEN THE WORLD DECLARES IN ONE VOICE:

WE WILL NOT GO QUIETLY INTO THE NIGHT!!!!!!!!!!

WE WILL NOT VANISH WITHOUT A FIGHT!!!!!!!!!!

WE ARE GOING TO LIVE ON!!!!!!!!!

WE ARE GOING TO SURVIVE!!!!!!!!!!

TODAY, WE CELEBRATE OUR INDEPENDENCE FROM THE CABAL!!!!!!!!!!



GOOD LUCK AND GOD BLESS!!!!!!!!!!!

Boopka

10/29/20 3:58 PM

#279326 RE: nidan7500 #279315

Nidan. Good digging. Just fyi, I sent the Alzheimer's Association an email with the announcement by Anavex of the CTAD presentation. Funny, I have sent multiple emails to the association and this is the first time they did not respond back to my email.

nidan7500

10/29/20 4:18 PM

#279331 RE: nidan7500 #279315

Why bother having an important AD conference bend it's agenda rules to accept/allow AVXL to do a piece on PDD results when the Chief FDA executive writes a memo identifying a BIG BREAK relating to AD Cause by another company?

How did AVXL even get on the November 6th conference agenda? Why,... if he (FDA) already had it BALLOON? ready to launch?

None of this makes sense, unless it is just all a politics and money game.

Pieces not fitting for me.

blu_1

10/30/20 9:54 AM

#279457 RE: nidan7500 #279315

Harry Johns is the president and CEO of the Alzheimer's Association, not the fda